Publication | Closed Access

Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer

NanomedicineHealth SciencesPolymer-drug ConjugateMedicineTumor Vessel NormalizationNano-drug DeliveryTumor TargetingAptamer-modified NanocomplexesPharmacologyRadiation OncologyTumor MicroenvironmentDrug Resistance